Author
Listed:
- Rozlyn Cruickshank
- Fatima Suleman
Abstract
BACKGROUND- Haematology patients are at a high risk of developing invasive candidiasis (IC). Fluconazole has been the mainstay of prophylaxis and treatment with a newer class of therapeutic options, the echinocandins, having seen a considerable improvement in treatment success. However, these agents are associated with substantial acquisition costs when compared to fluconazole. OBJECTIVE- This study analysed the direct treatment costs of invasive candidiasis in haematology patients, comparing the costs between three groups depending on the treatment, namely, the fluconazole only group, the echinocandin only group or the group that was treated with both fluconazole and an echinocandin. To determine which variables contributed to the overall costs and whether there were differences between the groups. METHODS- This was a retrospective, single-centre economic analysis at a private hospital of patients with IC in the haematology ward in Durban, KwaZulu-Natal Province, South Africa. The direct medical costs related to managing IC were analysed. Adult patients (≥18 years old) diagnosed with a haematology disorder and a positive blood culture for Candida who were prescribed fluconazole and/or an echinocandin as treatment were included in the study. Patients treated with echinocandins, fluconazole or both classes of antifungals were analysed separately and compared. RESULTS- No statistically significant difference for duration of antifungal treatment or length of hospital stay between the three groups existed. Mean overall direct treatment costs per patient were- ZAR130 326 (95% CI- -4 932 – 265 584) for patients treated with fluconazole, ZAR241 165 (95% CI- 159 175 – 323 155) for patients receiving an echinocandin and ZAR270 802 (95% CI- 68 277 - 473 327) for patients treated with the combination CONCLUSION- The results of this cost analysis found that treatment with fluconazole only is considerably less expensive, almost half of the mean daily treatment cost, than an echinocandin only and treatment using both agents, is less expensive than an echinocandin only as first-line therapy.
Suggested Citation
Rozlyn Cruickshank & Fatima Suleman, 2019.
"Direct Treatment Costs of Invasive Candidiasis in Haematology Patients at a South African Private Hospital,"
Global Journal of Health Science, Canadian Center of Science and Education, vol. 11(7), pages 1-60, July.
Handle:
RePEc:ibn:gjhsjl:v:11:y:2019:i:7:p:60
Download full text from publisher
More about this item
JEL classification:
- R00 - Urban, Rural, Regional, Real Estate, and Transportation Economics - - General - - - General
- Z0 - Other Special Topics - - General
Statistics
Access and download statistics
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ibn:gjhsjl:v:11:y:2019:i:7:p:60. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Canadian Center of Science and Education (email available below). General contact details of provider: https://edirc.repec.org/data/cepflch.html .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.